Eunice Kennedy Shriver National Institute of Child Health and Human Development

RFA-HD-23-008: 2022 NICHD Global Network for Women’s and Children’s Health Research: Research Units (UG1 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions in partnership with research centers in low and middle-income countries to submit applications as Research Units (RUs) to participate in the Global Network for Women’s and Children’s Health Research. RUs will consist of U.S.-based research centers applying in partnership with research centers in low- and lower middle-income countries as defined by the World Bank. The RU grantees will become part of a cooperative network in scientific partnership with the NIH to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-constrained settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality.

This Funding Opportunity Announcement (FOA) invites applications for Global Network Research Units; a separate FOA invites applications for a Global Network Data Coordinating Center.

Internal Deadline
External Deadline
11/29/2022

RFA-HD-23-009: 2022 NICHD Global Network for Women’s and Children’s Health Research: Data Coordinating Center (U24 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions to submit applications to participate in the Global Network for Women’s and Children’s Health Research’s Data Coordinating Center. The Data Coordinating Center will work with Research Units of U.S.-based research centers partnering with institutions in low- and lower middle-income countries to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-constrained settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality.

This Funding Opportunity Announcement (FOA) invites applications for a Global Network Data Coordinating Center; a separate FOA invites applications for Global Network Research Units.

Internal Deadline
External Deadline
11/29/2022

RFA-HD-23-023: 2022 Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

This FOA encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is available in pediatric pharmacology-related clinical and biomedical fields that currently have a limited number of researchers. This FOA will support essential research career development opportunities and ensure “protected” time to pursue impactful research experiences for new faculty-level clinical pharmacologists, fostering the transition to productive highly skilled clinical pharmacologist investigators.

This initiative proposes to expand and strengthen the community of clinical pharmacologist investigators engaged in pediatric clinical pharmacology research.

Internal Deadline
External Deadline
12/06/2022